Deepnoid teaches AI to learn lesion locations from radiology reports, securing basis for advanced medical AI
Predicted impact: Low
315640 · KOSDAQ · ₩315640 · 딥노이드
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−60.9% from the high
₩1,120Today: ₩1,709 – ₩1,763₩4,410
Returns
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals describe activity, not recommendations. Not financial advice.
Deepnoid (딥노이드, KRX: 315640) is listed on KOSDAQ, in the Software sector. The company develops artificial intelligence solutions in two segments: medical AI and industrial AI. Its shares closed at ₩1,725 on Oct 30, 2026, down 1.99% on the day, giving it a market value of ₩51B.
The company develops artificial intelligence solutions in two segments: medical AI and industrial AI. Its medical AI products, including DEEP:NEURO, DEEP:CHEST and DEEP:LUNG, assist clinicians with image reading and early disease diagnosis for hospitals and screening centers. Its industrial AI segment includes SkyMARU:SECURITY and DEEP:SECURITY for automated X-ray threat and information-security item detection for airports, data centers, government agencies and companies, and DEEP:FACTORY, a deep-learning vision inspection solution for manufacturers.
Written by AI from the company's latest annual report.
Predicted impact: Low
Predicted impact: Low
Airport security AI defense push is a vague product direction with no disclosed contract size.
Predicted impact: Low
Academic conference acceptances; research news with no financial size.
Titles in Korean until English translations are added.
Also known as: Deepnoid / 딥노이드 / 315640 / KRX:315640
Source: KRX statistical information